Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Forum Markets Incorporated, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Surgery Partners Inc. June 6, 202588.1%
-
LifeStance Health Group Inc. June 3, 202590.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 18, 2026 | Surgery Partners Inc. | Open-market purchase | +10,000 | $14.35 | $143,500 |
| Aug 14, 2026 | LifeStance Health Group Inc. | Open-market sale | −7,500 | $12.68 | $95,100 |
| Aug 13, 2026 | LifeStance Health Group Inc. | Open-market sale | −20,441 | $12.23 | $249,993 |
| Jul 2, 2026 | LifeStance Health Group Inc. | Grant or award | +17,746 | — | — |
| Jun 5, 2026 | Surgery Partners Inc. | Grant or award | +11,670 | $13.71 | $159,996 |
| Aug 11, 2025 | Surgery Partners Inc. | Open-market sale | −20,018 | $22.74 | $455,209 |
| Jun 11, 2025 | LifeStance Health Group Inc. | Grant or award | +35,714 | — | — |
| Jun 10, 2025 | Surgery Partners Inc. | Grant or award | +6,861 | $23.32 | $159,999 |
| Aug 14, 2024 | LifeStance Health Group Inc. | Grant or award | +35,211 | — | — |
| Jul 21, 2024 | LifeStance Health Group Inc. | Grant or award | +36,363 | — | — |
| Jun 6, 2024 | Surgery Partners Inc. | Grant or award | +6,170 | $25.93 | $159,988 |
| Jun 1, 2023 | Surgery Partners Inc. | Grant or award | +4,192 | $38.16 | $159,967 |
Questions about Teresa DeLuca
What boards is Teresa DeLuca on?
Teresa DeLuca sits on the boards of Forum Markets Incorporated, LifeStance Health Group Inc. and Surgery Partners Inc.
How long has Teresa DeLuca served on boards?
Our records show at least 9 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.